Fu X - Search Results

1

The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy.

Wu X, Zhou F, Ji X, Ren K, Shan Y, Mao X, Fen Y, Chen R, Ding H, Fu X. Wu X, et al. Among authors: fu x. Future Oncol. 2017 Dec;13(29):2691-2696. doi: 10.2217/fon-2017-0426. Epub 2017 Oct 3. Future Oncol. 2017. PMID: 28972404

2

Prognostic value of TROP2 expression in patients with gallbladder cancer.

Chen MB, Wu HF, Zhan Y, Fu XL, Wang AK, Wang LS, Lei HM. Chen MB, et al. Tumour Biol. 2014 Nov;35(11):11565-9. doi: 10.1007/s13277-014-2469-9. Epub 2014 Aug 19. Tumour Biol. 2014. PMID: 25135430

3

Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer.

Lin YL, Wang YL, Fu XL, Li WP, Wang YH, Ma JG. Lin YL, et al. Oncotarget. 2016 May 10;7(19):28384-92. doi: 10.18632/oncotarget.8635. Oncotarget. 2016. PMID: 27070091 Free PMC article.

4

Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.

Fu XL, Fang Z, Shu LH, Tao GQ, Wang JQ, Rui ZL, Zhang YJ, Tian ZQ. Fu XL, et al. Oncotarget. 2017 May 23;8(21):34340-34351. doi: 10.18632/oncotarget.16127. Oncotarget. 2017. PMID: 28423720 Free PMC article.

5

Elevated serum Activin A in chronic obstructive pulmonary disease with skeletal muscle wasting.

Zhou G, Gui X, Chen R, Fu X, Ji X, Ding H. Zhou G, et al. Among authors: fu x. Clinics (Sao Paulo). 2019;74:e981. doi: 10.6061/clinics/2019/e981. Epub 2019 Jun 27. Clinics (Sao Paulo). 2019. PMID: 31271588 Free PMC article.

6

Aberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma.

Lin YL, Wang YL, Fu XL, Ma JG. Lin YL, et al. Med Sci Monit. 2014 Nov 22;20:2380-5. doi: 10.12659/MSM.892433. Med Sci Monit. 2014. PMID: 25416427 Free PMC article.

7

Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer.

Wang G, Wang JJ, Zhi-Min Z, Xu XN, Shi F, Fu XL. Wang G, et al. Sci Prog. 2023 Jan-Mar;106(1):368504221147173. doi: 10.1177/00368504221147173. Sci Prog. 2023. PMID: 36718538 Free PMC article. Review.

8

miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.

Shi L, Wang Z, Sun G, Wan Y, Guo J, Fu X. Shi L, et al. Among authors: fu x. Neuromolecular Med. 2014 Jun;16(2):517-28. doi: 10.1007/s12017-014-8305-y. Epub 2014 Apr 29. Neuromolecular Med. 2014. PMID: 24777293

9

Promoter methylation of protocadherin8 is an independent prognostic factor for biochemical recurrence of early-stage prostate cancer.

Niu WB, Gui SL, Lin YL, Fu XL, Ma JG, Li WP. Niu WB, et al. Med Sci Monit. 2014 Dec 8;20:2584-9. doi: 10.12659/MSM.893083. Med Sci Monit. 2014. PMID: 25486497 Free PMC article.

10

Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.

Lin YL, Deng QK, Wang YH, Fu XL, Ma JG, Li WP. Lin YL, et al. Med Sci Monit. 2015 Dec 19;21:3955-690. doi: 10.12659/msm.896763. Med Sci Monit. 2015. PMID: 26683656 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,662 results

Search Page

Filters